Snap Shares Tumble After Insiders Get First Opportunity to Sell
(Bloomberg) -- Snap Inc. shares fell Monday after some inside holders got their first opportunity to sell since the March initial public offering.
The shares tumbled as much as 5.1 percent to $13.10 in New York, 23 percent below the company's $17 IPO price.
Inside holders, such as executives and investors from the company's days as a private startup, are barred from selling their shares for a certain period after the IPO. JPMorgan Chase & Co. had estimated that as many as 400 million shares could be sold in the first lockup expiration.
While some early investors are finally able to cash out on their holdings, putting more stock into the market also puts pressure on the price. Snap, the maker of the Snapchat app for sending fun, disappearing photos and videos, has already seen its value decline since the IPO. Investors have voiced concerns that Snap won't be able to grow its user base quickly enough to claim a strong position in an increasingly competitive digital advertising market, especially as Facebook Inc.'s properties copy some of Snapchat's most compelling features.
“Sentiment around Snap remains at ghastly levels,” Brian White, an analyst at Drexel Hamilton, wrote in a note to investors this month. But once all the lockups have expired, the weakened stock could be “a buying opportunity for investors that can look out twelve months,” he said.
Snap reports earnings for the second time as a listed company on August 10.
To contact the reporter on this story: Sarah Frier in San Francisco at sfrier1@bloomberg.net.
To contact the editors responsible for this story: Jillian Ward at jward56@bloomberg.net, Molly Schuetz, Kim Robert McLaughlin
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.